Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Omnicell (OMCL) Research & Development (2016 - 2026)

Omnicell has reported Research & Development over the past 16 years, most recently at $22.6 million for Q4 2025.

  • Quarterly Research & Development fell 13.39% to $22.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.7 million through Dec 2025, down 1.92% year-over-year, with the annual reading at $88.7 million for FY2025, 1.92% down from the prior year.
  • Research & Development was $22.6 million for Q4 2025 at Omnicell, down from $24.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $28.4 million in Q4 2022 and troughed at $16.1 million in Q1 2021.
  • The 5-year median for Research & Development is $22.7 million (2023), against an average of $22.8 million.
  • Year-over-year, Research & Development dropped 13.79% in 2021 and then skyrocketed 55.66% in 2022.
  • A 5-year view of Research & Development shows it stood at $21.9 million in 2021, then grew by 29.47% to $28.4 million in 2022, then fell by 5.61% to $26.8 million in 2023, then dropped by 2.9% to $26.0 million in 2024, then fell by 13.39% to $22.6 million in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Research & Development are $22.6 million (Q4 2025), $24.0 million (Q3 2025), and $21.6 million (Q2 2025).